Activity

Mediation analyses indicated that anti-bisexual prejudice was indirectly associated with greater PTSD symptoms through lower social support. Addressing bisexual-specific minority stress and its role in diminishing social support for bisexual individuals represents a critical component of trauma-informed research and intervention development in the bisexual community.The aims of this systematic review were to synthetize the current evidence about (i) the force-velocity (FV) profile parameters (maximal values of force [F0], velocity (V0), and power [Pmax]) obtained from the Samozino’s method in different sports; (ii) the association of the FV profile parameters with sport performance outcomes; and (iii) the effects of specific training programmes on the FV profile parameters. PubMed, SportDiscus, Web of Science, and Medline databases were searched for articles published between October 2008 (conception of the Samozino’s method) and October 2020. Twenty-one studies (10 descriptive, 6 correlational, and 5 longitudinal) met the inclusion criteria. The main findings revealed greater F0, Pmax, and V0 values and better jump/sprint performance for high-level athletes compared to their low-level counterparts. The vertical Pmax showed the highest correlation with jump height. The horizontal F0, Pmax, and V0 were nearly perfectly correlated with 5/10-m, 10/20-m and 30/40-m sprint times, respectively. Training programmes using heavy- or light-loads specifically enhanced F0 and V0, respectively. These results suggest that the FV profile parameters discriminate between athletes of different sport disciplines and levels of practice, present significant correlations with a number of sport performance outcomes, and can be modified after short-term training programmes.

This population pharmacokinetic-pharmacogenetic study aimed to investigate the optimal dose of RTV-boosted ATV (ATV/RTV) for Thai adult HIV-infected patients.

A total of 1460 concentrations of ATV and RTV from 544 patients receiving an ATV/RTV-based regimen were analyzed. The

6986A>G,

3435C>T,

2677G>T,

521T>C and

63396C>T were genotyped. A population pharmacokinetic model was performed using a nonlinear mixed-effect model (NONMEM

). Monte Carlo simulations were conducted to compare the percentages of patients achieving the therapeutic range of ATV trough concentrations (C

).

The apparent oral clearance of ATV (CL/F

) without RTV was 7.69 L/h with interindividual variability (IIV) of 28.7%. Patients with

6986 GG had a 7.1% lower CL/F

than those with AA or AG genotype. JNK-IN-8 molecular weight The CL/F

decreased by 10.8% for females compared with males. Simulation results showed higher percentages (~70%) of patient receiving doses of 200/100 or 200/50 mg achieved the ATV C

of 0.15-0.85 mg/L, while more patients (~40%) receiving a standard dose (300/100 mg) had ATV C

above this target.

Both

6986A>G and female decreased CL/F

in Thai HIV-infected patients. Simulations supported that the reduced dose of ATV/RTV was sufficient to achieve the target concentration for Thai population.

G and female decreased CL/FATV in Thai HIV-infected patients. Simulations supported that the reduced dose of ATV/RTV was sufficient to achieve the target concentration for Thai population.

This study reports analytical and clinical validation of a molecular signature response classifier (MSRC) that identifies rheumatoid arthritis (RA) patients who are non-responders to tumor necrosis factor-ɑ inhibitors (TNFi).

The MSRC integrates patient-specific data from 19 gene expression features, anti-cyclic citrullinated protein serostatus, sex, body mass index, and patient global assessment into a single score.

The MSRC results stratified samples (N=174) according to non-response prediction with a positive predictive value of 87.7% (95% CI 78-94%), sensitivity of 60.2% (95% CI 50-69%), and specificity of 77.3% (95% CI 65-87%). The 25-point scale was subdivided into three thresholds signal not detected (<10.6), high (≥10.6), and very high (≥18.5). The MSRC relies on sequencing of RNA extracted from blood; this assay displays high gene expression concordance between inter- and intra-assay sample (R

>0.977) and minimal variation in cumulative gene assignment diversity, read mapping location, or gene-body coverage. The MSRC accuracy was 95.8% (46/48) for threshold concordance (no signal, high, very high). Intra- and inter-assay precision studies demonstrated high repeatability (92.6%, 25/27) and reproducibility (100%, 35/35).

The MSRC is a robust assay that accurately and reproducibly detects an RA patient’s molecular signature of non-response to TNFi therapies.

The MSRC is a robust assay that accurately and reproducibly detects an RA patient’s molecular signature of non-response to TNFi therapies.Plant-derived phytoconstituents are well known for their therapeutic potential. It has been experimentally demonstrated that whole-plant extract or isolated phytoconstituents reveal various therapeutic potentials like hepatoprotective, antimicrobial, neuroprotective, antitumor, antioxidant, skin protectives, etc. Although these phytoconstituents have potential therapeutic benefits, their use is limited due to their poor bioavailability, stability in biological fluids, and authentication issues. These continue to be an open problem that affects the application of these valuable ancient herbal herbs in the effective treatment and management of various disease conditions. A potential solution to these difficult problems could be the loading of phytoactives in phospholipid-based vesicular systems. Phospholipid-based vesicles like liposomes, phytosomes, ethosomes as well as transfersomes were effectively utilized recently to solve drawbacks and for effective delivery of phytoactives. Several landmark studies observed better therapeutic efficacy of phytoactive loaded vesicles compared to conventional drug delivery. Thus phospholipid-based vesicles mediated phytoactive delivery is a recently developed promising and attractive strategy for better therapeutic control on disease conditions. The present short review highlights recent advances in herbal bioactive loaded phospholipid-based vesicles.

In the UK, core surgical training (CST) is the first specialty experience that early-career surgeons receive but training differs significantly across CST deaneries. To identify the impact these differences have on trainee performance, we assessed whether success at the Membership of the Royal College of Surgeons (MRCS) examinations is associated with CST deanery.

A retrospective cohort study of UK trainees in CST who attempted MRCS between 2014 and 2020 (

 = 1104). Chi-squared tests examined associations between locality and first-attempt MRCS performance. Multivariate logistic regression models identified the likelihood of MRCS success depending on CST deanery.

MRCS Part A and Part B pass rates were associated with CST deanery (

 < 0.001 and

 = 0.013, respectively). Candidates that trained in Thames Valley (Odds Ratio [OR] 2.52 (95% Confidence Interval [CI] 1.00-6.42), North Central and East London (OR 2.37 [95% CI 1.04-5.40]) or South London (OR 2.36 [95% CI 1.09-5.10]) were each more than twice as likely to pass MRCS Part A at first attempt. Trainees from North Central and East London were more than ten times more likely to pass MRCS Part B at first attempt (OR 10.59 [95% CI 1.23-51.00]). However, 68% of candidates attempted Part A prior to CST and 48% attempted Part B before or during the first year of CST.

MRCS performance is associated with CST deanery; however, many candidates passed the exam with little or any CST experience suggesting that some deaneries attract high academic performers. MRCS performance is therefore not a suitable marker of CST training quality.

MRCS performance is associated with CST deanery; however, many candidates passed the exam with little or any CST experience suggesting that some deaneries attract high academic performers. MRCS performance is therefore not a suitable marker of CST training quality.Beyond MYC rearrangement, Burkitt lymphoma (BL) often presents with additional aberrations. Biopsy touch imprints from 72 children with BL were tested with interphase fluorescence in-situ hybridization (i-FISH) for MYC, BCL2, BCL6, IGH, IGK and IGL rearrangements and copy-number aberrations involving 1q21/1p32, 7cen/7q31, 9cen/9p21, 13q14/13q34 and 17cen/17p13. Diploid status deviations were investigated with chromosome enumeration probes. MYC rearrangement was demonstrated in all cases. Additional aberrations included +1q (21/7229.2%), +7q (14/7219.4%), 13q- (14/7219.4%), 9p-(6/728.3%) and hyperdiploidy (6/728.3%). Advanced clinical stage IV, +7q and 9p- were associated with shorter overall survival, with stage IV and +7q retaining prognostic significance on multivariate analysis. No relapse or death was reported among the hyperdiploid cases. This i-FISH investigation provides information on the genetic profile of BL and may prove valuable for patients with no karyotype analysis. Demonstration of hyperdiploidy could evolve research on clonal evolution pathways and probably identify a subgroup of children with favorable prognosis.

To retrospectively compare the efficacy and safety of surgical resection (SR) and thermal ablation for the treatment of adrenal metastases.

From January 2008 to December 2018, 133 patients with adrenal metastases who underwent SR (

 = 76) or thermal ablation (

 = 57) were enrolled. The mean tumor size was 58.00 ± 10.65 mm (22-80 mm) in the SR group and 58.03 ± 12.76 mm (34-89 mm) in the thermal ablation group. Local progression-free survival (LPFS) and safety were compared between the two groups using the Kaplan-Meier method and log-rank tests. Cox proportional hazard regression models were used to evaluate the prognostic factors of LPFS. Complications, hospitalization days, and blood loss were also assessed.

The median follow-up was 29.0 months (range, 20.4-37.6 months). No treatment-related mortality was observed. The 1-, 3- and 5-year LPFS rates were 74.0%, 62.8%, and 31.4% in the SR group and 72.8%, 68.7%, and 51.5% in the ablation group, with the median LPFS of 41.5 months (95% CI 9.3-23.4 months) vs. 47.9 months (95% CI 20.6-75.8 months), respectively (

 = 0.784). Tumor size ≥3 cm was the only significant risk factor for LPFS (

 = 0.031). The ablation group was superior to the SR group with a lower major complication rate (4.1% vs. 14.5%,

 = 0.03), less blood loss (1 ml vs. 100 ml,

 < 0.001), and a shorter hospital stay (2 d vs. 6 d,

 < 0.001).

Thermal ablation provided a similar LPFS and less comorbidities than SR, indicating that it is an effective and safe treatment for adrenal metastases.

Thermal ablation provided a similar LPFS and less comorbidities than SR, indicating that it is an effective and safe treatment for adrenal metastases.Optic nerve infiltration secondary to systemic non-Hodgkin lymphoma (NHL) is a rare phenomenon. We present a 55-year-old man with low-grade systemic NHL who initially presented with an isolated optic neuropathy and non-specific neurological symptoms. We further present a literature review of systemic NHL with radiological evidence of optic nerve infiltration. On magnetic resonance imaging, the characteristic features include optic nerve enhancement and enlargement, while leptomeningeal enhancement is uncommon. Cerebrospinal fluid analysis and optic nerve sheath biopsy can return false negative results, and when such investigations are inconclusive, biopsy of the optic nerve substance has a high diagnostic yield. Although rare, lymphomatous optic nerve infiltration must be considered in the differential diagnosis of a pale swollen optic disc.